在焦点患者中管理延迟或遗漏的普雷加巴林剂量:蒙特卡洛模拟研究
Helin Xie1, You Zheng1,2, Chenyu Wang3
1Department of Pharmacy, Fujian Medical University Union Hospital, Gulou District, 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
International journal of clinical pharmacy
|November 22, 2023
概括
对于患者错过了普雷加巴林剂量,具体的补救策略,考虑到延迟持续时间和功能,比通用建议更有效. 模拟显示,量身定制的剂量可以补偿错过或延迟的药物.
科学领域:
- 药理学和临床药学 药理学和临床药学
- 症管理 症管理
- 药理动力学 药理动力学
背景情况:
- 药物不服药,包括延迟或遗漏剂量,在药物治疗中很常见.
- 目前美国食品和药物管理局 (FDA) 关于管理不服药的指南缺乏强有力的临床证据.
研究的目的:
- 评估治疗策略延迟或错过患者的普雷加巴林剂量.
- 使用蒙特卡洛模拟来评估各种粘附场景.
主要方法:
- 采用了一种已发表的pregabalin人口药动力学模型.
- 模拟了8个人群的坚持情景,包括患有功能障碍的人.
- 评估了五个建议的补救方案以及FDA的建议.
主要成果:
- 补救策略的有效性因延迟的持续时间和患者的功能而异.
- 对于短暂的延迟,建议立即定期服用剂量.
- 根据功能 (1-12小时) 确定了定期剂量给药的特定截止时间.
- 当延迟接近剂量间隔时,定期和部分剂量的组合是有效的.
- 在下一个预定时间服用1.3倍的常规剂量通常可以弥补错过的剂量.
结论:
- 基于模型的模拟提供了量化证据,支持错过或延迟的普雷加巴林剂量的特定补救策略.
- 这些策略是有效的和可行的,以改善患者的药物坚持.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
419
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
419
Antiepileptic Drugs: Potassium Channel Activators
188
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
188
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
317
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
317
Antiepileptic Drugs: Glutamate Antagonists
380
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
380
Antiepileptic Drugs: Sodium Channel Blockers
597
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
597
Antiepileptic Drugs: Calcium Channel Blockers
417
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
417


